CONTACT US
-
Recro Pharma, Inc.
490 Lapp Road
Malvern, PA 19355
Phone: 484-395-2470
Fax: 484-395-2471
Email: info@recropharma.com
Click Here for Directions
January 2010:
DEX-TD Phase I Clinical
Study initiated.
December 2009:
William Ashton joins Board
of Directors.
September 2009:
DEX-SL Phase I Clinical Study initiated in the U.S.
